Back

The prevalence and assessment of cardiovascular symptoms as the risk factors for post-COVID syndrome at 12-month follow-up. Data from the Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study.

28 August 2023 (14:15 - 14:40)
Organised by: Logo
Congress Presentation Part of: COVID-19 and heart disease Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Piotr Jankowski

The Medical Centre of Postgraduate Education, Warsaw (Poland)

3 More presentations in this session

Presentation thumbnail
Symptom burden, coagulopathy and heart disease, and quality of life at baseline and after 1-year follow-up following acute SARS-CoV-2 infection in a community medicine setting
Doctor R. Colleran (Dublin 7, IE)
Abstract Slides
Presentation thumbnail
The role of the peripheral chemoreceptor reflex in non-hospitalised patients with post-COVID-19 syndrome
Doctor A. El-Medany (Bristol, GB)
Abstract Slides Video
Presentation thumbnail
Postural orthostatic tachycardia syndrome (POTS) and other autonomic dysfunction following COVID-19 infection: incidence, characteristic and associating factors
Doctor C. tanking (Bangkok, TH)
Abstract Slides Video

Access the full session

Session thumbnail
COVID-19 and heart disease

The Event

Event poster

ESC Congress 2023

28 August 2023 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources